Synagis Prior Authorization Begins For All Health Service Regions
HHSC will allow Synagis prior authorization for respiratory syncytial virus (RSV) treatment for all state health regions on the following dates:
- Oct. 16, 2023, for regions 3, 4, 5, 6, 7, and 8
- Nov. 1, 2023, for regions 1, 2, 9, and 10
HHSC opened region 11 on Oct. 2. The schedule is staggered and based on a patient's county of residence at the start of the season. Refer to the schedule for start dates and the regional map.
Prescribing providers must prescribe Synagis to infants meeting the criteria described on the American Academy of Pediatrics website. These criteria did not change from the 2022-2023 season.
The option to purchase and bill through TMHP is not available this season.
We will not open other areas at this time. HHSC will continue working with the Texas Pediatric Society's task force to determine the RSV prophylaxis schedule for the other regions and will provide additional instruction.
Prior Authorization Requests
For Medicaid Managed Care and CHIP
Prescribing providers must contact the patient's MCO for prior authorization forms and instructions. You can use the MCO Search to find contact information for each MCO.
For Traditional Medicaid
Prescribing providers obtain Synagis prescribed for a specific infant from participating pharmacies through the Vendor Drug Program using the Medicaid Synagis Authorization Addendum (HHS Form 1321) on Sept. 25.
You must complete the form and send it to the dispensing pharmacy. Pharmacy staff will then fax the form to the Texas Prior Authorization Call Center for processing. You can call the Texas Prior Authorization Center at 877-728-3927 for questions or assistance with the form.
For the Children with Special Health Care Needs Services Program
Providers obtain Synagis through the CSHCN Services Program and should use the CSHCN Services Program Synagis Prior Authorization Addendum (HHS Form 1325). Providers can call the CSHCN Services Program at 800-252-8023 for questions or assistance with the form.